这些人很靠谱。一切都透明,报告定期送达,说到做到。没有隐藏信息,我查过
Compass Therapeutics: A 50% Price Cut Hiding A Regulatory Mispricing Opportunity | Seeking AlphaAmazon senior cloud executive departs after 18 yearsWhy Jim Cramer is shocked by Citi's against-the-grain praise of Microsoft's CopilotFranklin Federal Tax-Free Income Fund Q2 2026 Commentary (MUTF:FAFTX) | Seeking AlphaFractured Iran Makes Hormuz Flare-Ups Inevitable, Is China The Key? (SPY) | Seeking Alpha

Business
The tech trade has grown "tired" despite fundamentally positive indicators for the AI infrastructure cycle, said Gene Munster, co-founder of Deepwater Asset Management. In an interview with CNBC, Munster emphasized that recent market pullbacks are driven by psychology rather than deteriorating The…

Business
Compass Therapeutics, Inc. (CMPX) is a pre-revenue oncology company that focuses on developing bispecific antibodies. The stock is currently trading at around $2.27, which is about 50% lower than what it was trading at roughly 3 months I started my investing journey at age 18, and over the years, I…
暂无文章
文章发表后将在此处显示。
